# Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer

Source: https://onco.cc/trials/nct07419880/  
OnCo record `nct07419880` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of TQB2102 in triple-negative breast cancer, run by Fudan University, not yet recruiting.

## Summary

Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer is a phase 2, interventional study registered as NCT07419880 by Fudan University, with a registry enrolment figure of 46 participants, started 2026-01-30 and due to reach its primary completion in 2027-01-30. Interventions recorded: Cromolyn, TQB2102, and Panpulimab. Conditions listed: Triple -Negative Breast Cancer. Triple-negative eligibility wording from the registry: "Diagnosis: Histologically confirmed invasive triple-negative breast cancer (defined as: ER-negative by IHC with \<1% positive tumor cells; PR-negative with \<1% positive tumor cells; HER2 0-1+ or HER2 2+ with confirmed negative FISH/CISH without amplification)". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Also known as: RECLAIM
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT07419880
- Phase: 2
- Setting: RECLAIM: Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer
- Sponsor: Fudan University
- Enrolled: 46

## Sources

- ClinicalTrials.gov NCT07419880: https://clinicaltrials.gov/study/NCT07419880

## Connected records

- cancers: [Early triple-negative breast cancer](https://onco.cc/cancers/tnbc-early/)
- drugs: [TQB2102](https://onco.cc/drugs/tqb2102/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07419880.json